Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-Term Odanacatib Fracture Trial

被引：0

作者：

McClung, Michael R. ^{[1
]}

Langdahl, Bente ^{[2
]}

Papapoulos, Socrates ^{[3
]}

Saag, Kenneth G. ^{[4
]}

Bone, Henry ^{[5
,6
]}

Kiel, Douglas P. ^{[7
]}

Lippuner, Kurt ^{[8
]}

Nakamura, Toshitaka ^{[9
]}

Reid, Ian ^{[10
]}

Heyden, Norman ^{[11
]}

DaSilva, Carolyn ^{[11
]}

Scott, Boyd B. ^{[11
]}

Massaad, Rachid ^{[12
]}

Kaufman, Keith D. ^{[11
]}

Stoch, Aubrey ^{[11
]}

Santora, Arthur ^{[11
]}

Gurner, Deborah ^{[11
]}

Lombardi, Antonio ^{[11
]}

机构：

[1] Oregon Osteoporosis Ctr, Portland, OR USA

[2] Aarhus Univ Hosp, Aarhus, Denmark

[3] Leiden Univ, Med Ctr, Leiden, Netherlands

[4] Univ Alabama Birmingham, Birmingham, AL USA

[5] Michigan Bone & Mineral Clin, Detroit, MI USA

[6] St Lukes Hosp, Osteoporosis Ctr, Chesterfield, MO USA

[7] Harvard Med Sch, Hebrew Senior Life, Inst Aging Res, Boston, MA USA

[8] Bern Univ Hosp, Bern, Switzerland

[9] Univ Occupat & Environm Hlth, Fukuoka, Japan

[10] Univ Auckland, Auckland, New Zealand

[11] Merck & Co Inc, Kenilworth, NJ USA

[12] MSD Europe Inc, Brussels, Belgium

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1027

引用

页数：2

共 50 条

[1] Odanacatib Efficacy and Safety in Postmenopausal Women with Osteoporosis: 5-Year Data from the Extension of the Phase 3 Long-term Odanacatib Fracture Trial (LOFT)
McClung, Michael R.
Langdahl, Bente
Papapoulos, Socrates
Saag, Kenneth G.
Bone, Henry
Kiel, Douglas P.
Lippuner, Kurt
Nakamura, Toshitaka
Reid, Ian
Heyden, Norman
DaSilva, Carolyn
Scott, Boyd B.
Massaad, Rachid
Kaufman, Keith D.
Stoch, S. Aubrey
Santora, Arthur
Gurner, Deborah
Lombardi, Antonio
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1369 - 1369
[2] Efficacy of Odanacatib in Postmenopausal Women with Osteoporosis: Subgroup Analyses of Data from the Phase 3 Long-Term Odanacatib Fracture Trial
Saag, Kenneth G.
Alexandersen, Peter
Benhamou, Claude-Laurent
Gilchrist, Nigel
Halse, Johan
Lewiecki, E. Michael
Lippuner, Kurt
McClung, Michael
Shiraki, Masataka
DaSilva, Carolyn A.
Verbruggen, Nadia
Scott, Boyd B.
Lombardi, Antonio
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[3] Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension
Recker, Robert
Dempster, David
Langdahl, Bente
Giezek, Hilde
Clark, Seth
Ellis, Graham
de Villiers, Tobias
Valter, Ivo
Zerbini, Cristiano A. F.
Cohn, Dosinda
Santora, Arthur
Duong, Le T.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (07) : 1289 - 1299
[4] EFFICACY OF ODANACATIB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: SUBGROUP ANALYSES OF DATA FROM THE PHASE 3 LONG-TERM ODANACATIB FRACTURE TRIAL (LOFT)
Saag, K. G.
Alexandersen, P.
Benhamou, C. -L.
Gilchrist, N.
Halse, J.
Lewiecki, E. M.
Lippuner, K.
McClung, M.
Shiraki, M.
DaSilva, C. A.
Verbruggen, N.
Scott, B. B.
Lombardi, A.
[J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S50 - S51
[5] ODANACATIB ANTIFRACTURE EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL (LOFT)
McClung, M. R.
Langdahl, B.
Papapoulos, S.
Saag, K. G.
Adami, S.
Bone, H. G.
De Villiers, T.
Kiel, D. P.
Kung, A.
Kumar, P. K. M.
Lim, S. -K.
Ling, X.
Lippuner, K.
Mautalen, C.
Nakamura, T.
Reginster, J. -Y.
Reid, I. R.
Rodriguez-Portales, A.
Roux, C.
Walliser, J.
Watts, N. B.
Zanchetta, J.
Zerbini, C. A. F.
Rybak-Feiglin, A.
Cohn, D.
DaSilva, C. A.
Massaad, R.
Santora, A. C.
Scott, B. B.
Kaufman, K. D.
Verbruggen, N.
Leung, A.
Lombardi, A.
[J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S35 - S36
[6] Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial
McClung, Michael R.
Langdahl, Bente
Papapoulos, Socrates
Saag, Kenneth G.
Adami, Silvano
Bone, Henry G.
de Villiers, Tobias
Kiel, Douglas P.
Kung, Annie
Kumar, Prasanna
Lim, Sung-Kil
Ling, Xu
Lippuner, Kurt
Mautalen, Carlos
Nakamura, Toshitaka
Reginster, Jean-Yves
Reid, Ian R.
Adolfo Rodriguez-Portales, Jose
Roux, Christian
Walliser, Jesus
Watts, Nelson B.
Zanchetta, Jose R.
Zerbini, Cristiano A. F.
Rybak-Feiglin, Andrea
Cohn, Dosinda
DaSilva, Carolyn A.
Massaad, Rachid
Santora, Arthur
Scott, Boyd B.
Verbruggen, Nadia
Leung, Albert
Lombardi, Antonio
[J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S987 - S987
[7] ODANACATIB ANTI-FRACTURE EFFICACY AND SAFETY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL
McClung, M. R.
Langdahl, B.
Papapoulos, S.
Saag, K. G.
Adami, S.
Bone, H. G.
de Villiers, T.
Kiel, D. P.
Kung, A.
Kumar, P.
Lim, S. -K.
Ling, X.
Lippuner, K.
Mautalen, C.
Nakamura, T.
Reginster, J. -Y.
Reid, I. R.
Rodriguez-Portales, J. A.
Roux, C.
Walliser, J.
Watts, N. B.
Zanchetta, J.
Zerbini, C. A.
Rybak-Feiglin, A.
Cohn, D.
DaSilva, C. A.
Massaad, R.
Santora, A.
Scott, B. B.
Verbruggen, N.
Leung, A.
Lombardi, A.
[J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 573 - 575
[8] SAFETY AND TOLERABILITY OF ODANACATIB THERAPY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE PHASE III LONG-TERM ODANACATIB FRACTURE TRIAL
Papapoulos, S.
McClung, M. R.
Langdahl, B.
Saag, K. G.
Adami, S.
Bone, H. G.
de Villiers, T.
Kiel, D. P.
Kung, A.
Kumar, P.
Lim, S. -K.
Ling, X.
Lippuner, K.
Mautalen, C.
Nakamura, T.
Reginster, J. -Y.
Reid, I. R.
Rodriguez-Portales, J. A.
Roux, C.
Walliser, J.
Watts, N. B.
Zanchetta, J.
Zerbini, C. A.
Rybak-Feiglin, A.
Cohn, D.
DaSilva, C. A.
De Tilleghem, C. Le Bailly
Santora, A.
Scott, B. B.
Verbruggen, N.
Leung, A.
Lombardi, A.
Gurner, D.
[J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 604 - 605
[9] Odanacatib Anti-Fracture Efficacy and Safety in Postmenopausal Women with Osteoporosis. Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT).
McClung, Michael
Langdahl, Bente
Papapoulos, Socrates
Saag, Kenneth
Adami, Silvano
Bone, Henry
de Villiers, Tobias
Kiel, Douglas
Kung, Annie
Kumar, Prasanna
Lim, Sung-Kil
Ling, Xu
Lippuner, Kurt
Mautalen, Carlos
Nakamura, Toshitaka
Reginster, Jean-Yves
Reid, Ian
Rodriguez Portales, Jose
Roux, Christian
Walliser, Jesus
Watts, Nelson
Ruben Zanchetta, Jose
Zerbini, Cristiano
Rybak-Feiglin, Andrea
Cohn, Dosinda
DaSilva, Carolyn
Massaad, Rachid
Santora, Arthur
Scott, Boyd
Verbruggen, Nadia
Leung, Albert
Lombardi, Antonio
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S51 - S51
[10] Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT).
Papapoulos, Socrates
McClung, Michael
Langdahl, Bente
Saag, Kenneth
Adami, Silvano
Bone, Henry
de Villiers, Tobias
Kiel, Douglas
Kung, Annie
Kumar, Prasanna
Lim, Sung-Kil
Ling, Xu
Lippuner, Kurt
Mautalen, Carlos
Nakamura, Toshitaka
Reginster, Jean-Yves
Reid, Ian
Adolfo Rodriguez-Portales, Jose
Roux, Christian
Walliser, Jesus
Watts, Nelson
Ruben Zanchetta, Jose
Zerbini, Christiano A. F.
Fybak-Feiglin, Andrea
Cohn, Dosinda
da Silva, Carolyn A.
De Tilleghem, Celine Le Bailly
Santora, Arthur
Scott, Boyd
Verbruggen, Nadia
Leung, Albert
Lombardi, Antonio
Gurner, Deborah
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S51 - S51

← 1 2 3 4 5 →